| |
| |
|
| Insider
Information: |
Henson Heidi |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
287,053 |
|
|
Indirect Shares
|
5,000 |
|
|
| Direct
Value |
$5,203,484 |
|
|
|
Indirect Value
|
$105,850 |
|
|
| Total
Shares |
292,053 |
|
|
| Total
Value |
$5,309,334 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anadys Pharmaceuticals Inc |
ANDS |
Officer |
2004-03-18 |
2,573 |
|
0 |
Premium* |
|
|
Kura Oncology Inc |
KURA |
Chief Financial Officer |
2016-12-13 |
245,000 |
2015-03-06 |
5,000 |
Premium* |
|
|
Pardes Biosciences Ord Shs |
PRDS |
Chief Financial Officer |
2023-08-31 |
0 |
|
0 |
Premium* |
|
|
Lisata Therapeutics Ord Shs |
LSTA |
Director |
2024-01-09 |
39,480 |
2023-01-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LSTA |
Lisata Therapeutics Ord S... |
Director |
– • – |
2024-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
19,480 |
39,480 |
0 |
- |
|
| PRDS |
Pardes Biosciences Ord Sh... |
Chief Financial Officer |
• – – |
2023-08-31 |
4 |
D |
$0.00 |
$0 |
D/D |
(316,753) |
0 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Director |
– • – |
2023-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
20,000 |
0 |
- |
|
| PRDS |
Pardes Biosciences Ord Sh... |
Chief Financial OfficerOfficer |
• – – |
2021-12-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
316,753 |
|
% |
|
| KURA |
Kura Oncology Inc |
Chief Financial Officer |
• – – |
2016-12-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
2,596 |
245,000 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
Chief Financial Officer |
• – – |
2015-11-11 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,000 |
247,596 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
Chief Financial OfficerOfficer |
• – – |
2015-03-06 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
250,596 |
|
- |
|
| KURA |
Kura Oncology Inc |
Chief Financial OfficerOfficer |
• – – |
2015-03-06 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,000 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Director of FinanceOfficer |
• – – |
2004-03-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,573 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
